FHLC — Fidelity MSCI Health Care Index ETF

FHLC Price Performance — Growth of $10,000

Value of a $10,000 investment in FHLC over time, compared with SPY. Both lines are rebased to $10,000 on the first shared date. Based on total returns — prices are adjusted for dividends and splits, so this assumes distributions were reinvested. Hover or tap the chart for exact values.

FHLC Drawdown

The "underwater" chart: FHLC's decline from its highest prior value at each point in time. It shows how deep past losses ran and how long the fund took to recover to break-even.

Overview

The Fidelity MSCI Health Care Index ETF (FHLC) is a healthcare-focused fund issued by Fidelity Investments with $3.54 billion in assets under management. It holds an overall rank of #64 out of 458 tracked ETFs and sits at #3 of 11 within its specific category, earning a B grade with a score of 74.3/100. The fund’s expense ratio of 0.084% is significantly lower than the category median of 0.36%, while its dividend yield of 1.18% exceeds the median of 0.98%. Concentration in the top ten holdings accounts for 51.9% of assets, with Eli Lilly & Co representing the largest single position at 13.3%.

Price action shows the fund trading at $85.99, which is 93.3% of its 52-week range between $68.46 and $87.25. Short-term momentum is evident with a 1.70% gain over one week and a 4.55% rise over one month, building on a stronger 8.83% return over three months. Longer-term performance remains robust, with a one-year return of 24.43% and a three-year total return of 55.23%. Despite the strong one-year figure, the fund’s return slightly trails the category median of 24.88%. The ETFValuer grade has remained unchanged at B across the last 35 tracked days, based on three years of available price history.

The fund exhibits a beta of 0.57, indicating it moves less than half as much as the broader market. Annualized volatility stands at 15.78%, which is labeled as moderate, while the maximum drawdown has reached -16.87%. A Sharpe ratio of 1.23 suggests favorable risk-adjusted returns relative to the volatility experienced. Liquidity is supported by an average daily volume of 241,582 shares. These metrics collectively describe a fund that has delivered returns with relatively constrained downside movement and steady trading activity.

AI-generated summary based on the data on this page.

FHLC Top Holdings

Holdings as of 2026-07-31 per the fund's most recent SEC N-PORT-P filing. Top 10 holdings make up 51.9% of net assets — a rough gauge of concentration risk (the higher this figure, the more the fund's return depends on a handful of names). To see how FHLC's holdings overlap with other ETFs you own or are considering, check the Stock Overlap tool.

Which Funds Overlap With FHLC

Holding two funds that own the same companies adds cost and complexity without adding much diversification. These tracked ETFs share the most names with FHLC's top 10 — XLV overlaps most, holding 9 of the same companies as FHLC's top 10 (49.9% of FHLC's assets).

Compares the top 10 reported holdings of each fund, so it's a floor on true overlap — two S&P 500 trackers overlap ~100% even when only 10 names are listed. Use the Stock Overlap tool to search by individual company.

Market Backdrop

10-Year Treasury Yield: 4.96% (as of 2026-10-22) — The yield on 10-year US Treasury bonds — the standard "risk-free rate" benchmark used to contextualize this fund’s Sharpe ratio and returns.

CBOE Volatility Index (VIX): 19.03 (as of 2026-10-22) — A real-time gauge of expected S&P 500 volatility over the next 30 days — useful context for this fund’s own volatility label.

Federal Funds Rate: 3.75% (as of 2026-09-01) — The Federal Reserve’s target policy rate, which anchors short-term borrowing costs across the economy.

FHLC Liquidity, Domicile & Tax Treatment

Liquidity: Average daily volume is 242K/day. Higher volume and a larger fund generally mean lower round-trip trading costs. AUM of $3.54B provides ample scale, supporting tight spreads and issuer commitment to keep the fund open.

Domicile & tax treatment: FHLC is a US-domiciled, SEC-registered ('40 Act) exchange-traded fund. Dividends and capital gains distributions are reported to US investors on Form 1099-DIV, and the fund is not subject to the PFIC reporting or UCITS-specific rules that apply to Irish- or Luxembourg-domiciled funds. Non-US investors should note that US-domiciled ETFs are generally subject to 30% US withholding tax on dividends (unless reduced by treaty) and to US estate tax exposure on the position — Irish-domiciled UCITS ETFs tracking the same index often avoid both, which is why non-US residents frequently prefer the UCITS equivalent where one exists. This is general information, not tax advice — consult a tax professional for your situation.

FHLC Performance History

How FHLC Compares to Other Healthcare ETFs